ClinicalTrials.Veeva

Menu

Lyspro Insulin vs Regular Insulin in Cirrhotic Patients

U

University of Campania "Luigi Vanvitelli"

Status and phase

Completed
Phase 4

Conditions

Cirrhosis
Diabetes Mellitus

Treatments

Drug: regular insulin
Drug: lyspro

Study type

Interventional

Funder types

Other

Identifiers

NCT00513201
Second University of Naples

Details and patient eligibility

About

OBJECTIVE: To compare lispro insulin and regular insulin in the glycemic control of patients with liver cirrhosis and type 2 diabetes subjects. METHODS: 108 patients with liver cirrhosis and type 2 diabetes were randomly treated with regular insulin or lispro. After 122 weeks a cross-over was carried out and patients followed-up for 122 weeks. Then, all patients received a standard breakfast of 145 kcal following 12 U.I. of regular insulin or lispro, and C-peptide and insulin serum levels were determined over 300 minutes.

Sex

All

Ages

48 to 67 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Insulin-treated diabetes mellitus and liver cirrhosis

Exclusion criteria

  • Oral hypoglycemic agents treated diabetes mellitus
  • Liver cancer

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems